Bio Essence annual operating margin
2020
2021
2022
2023
2024
2025
Bio Essence's operating margin was 47.43% for fiscal 2025.
View full Bio Essence company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 47.43% | +189.26 pp |
| 2024 | 2024-12-31 | −141.83% | −79.17 pp |
| 2023 | 2023-12-31 | −62.66% | +19.57 pp |
| 2022 | 2022-12-31 | −82.23% | +14.34 pp |
| 2021 | 2021-12-31 | −96.57% | −9.73 pp |
| 2020 | 2020-12-31 | −86.84% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 35.14% | +11.52 pp |
| Q1 2026 | 2026-03-31 | 43.11% | +967.41 pp |
| Q4 2025 | 2025-12-31 | 69.60% | +178.32 pp |
| Q3 2025 | 2025-09-30 | 10.42% | +406.18 pp |
| Q2 2025 | 2025-06-30 | 23.63% | +76.71 pp |
| Q1 2025 | 2025-03-31 | −924.30% | −907.67 pp |
| Q3 2024 | 2024-09-30 | −108.73% | −101.61 pp |
| Q2 2024 | 2024-06-30 | −395.76% | −295.49 pp |
| Q3 2023 | 2023-09-30 | −53.08% | +1.02 pp |
| Q2 2023 | 2023-06-30 | −16.63% | +57.27 pp |
| Q1 2023 | 2023-03-31 | −7.12% | +86.18 pp |
| Q3 2022 | 2022-09-30 | −100.27% | −15.27 pp |
| Q2 2022 | 2022-06-30 | −54.10% | +56.65 pp |
| Q1 2022 | 2022-03-31 | −73.90% | +22.57 pp |
| Q4 2021 | 2021-12-31 | −93.30% | +56.89 pp |
| Q3 2021 | 2021-09-30 | −85.00% | −3.04 pp |
| Q2 2021 | 2021-06-30 | −110.75% | −15.06 pp |
| Q1 2021 | 2021-03-31 | −96.46% | −57.18 pp |
| Q4 2020 | 2020-12-31 | −150.20% | — |
| Q3 2020 | 2020-09-30 | −81.96% | — |
| Q2 2020 | 2020-06-30 | −95.70% | — |
| Q1 2020 | 2020-03-31 | −39.28% | — |
Over the last five reported fiscal years, Bio Essence's operating margin increased from −86.84% to 47.43%, a change of +134.27 percentage points. The latest reported quarter, Q2 2026, shows 35.14%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bio Essence filings at SEC.gov ↗